Related Experiment Video

Updated: Jan 19, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.9K

Cancer vaccine development: on the way to break immune tolerance to malignant cells

Simone Mocellin1, Carlo Riccardo Rossi, Donato Nitti

  • 1Department of Oncological and Surgical Sciences, University of Padova, Italy. mocellins@hotmail.com

Experimental Cell Research
|September 8, 2004
PubMed

Insights

Harnessing the immune system offers a promising, non-toxic cancer treatment. Understanding immune tolerance, immune response synergy, and tumor microenvironment interactions is key to developing next-generation cancer vaccines.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Cancer immunotherapy leverages the body's natural defenses for non-toxic treatment.
  • Immune effectors influence tumor growth, but the precise mechanisms of tumor rejection are not fully understood.
  • Advancements in tumor immunology are crucial for improving cancer vaccine design.

Purpose of the Study:

  • To explore mechanisms of immune tolerance to cancer cells.
  • To investigate the synergistic interplay between innate and adaptive immune responses.
  • To analyze tumor-immune system interactions within the tumor microenvironment.

Main Methods:

  • Focus on cellular and molecular mechanisms of immune tolerance.
  • Examination of the synergistic effects between innate and adaptive immunity.
  • Analysis of the tumor microenvironment's role in immune interactions.

Main Results:

  • Identified key areas for novel cancer vaccine development.
  • Highlighted the importance of understanding immune tolerance in cancer.
  • Emphasized the need to study immune response synergism and tumor microenvironment dynamics.

Conclusions:

  • Further elucidation of tumor immunology is essential for effective cancer immunotherapy.
  • Novel vaccination strategies require a deep understanding of immune tolerance and response.
  • Targeting tumor-immune interactions within the microenvironment holds promise for future cancer vaccines.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.2K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
977
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K